Camillus, NY, United States of America

Charles Truman Holdrege

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Truman Holdrege. Retrieved from https://idiyas.com/inventor/charles-truman-holdrege

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Charles Truman Holdrege

Introduction

Charles Truman Holdrege is a notable inventor based in Camillus, NY (US). He has made significant contributions to the field of antibacterial agents, particularly through his innovative work on penicillanic acids. His research has focused on developing compounds that are effective in treating Pseudomonas infections.

Latest Patents

Holdrege holds a patent for antibacterial agents, specifically the penicillanic acids of the formula ##STR1## wherein Z is an oxygen or sulfur atom. These compounds, along with their pharmaceutically acceptable salts and physiologically hydrolyzed esters, possess antibacterial activity that is particularly valuable in medical treatments.

Career Highlights

Throughout his career, Holdrege has been associated with Bristol-Myers Company, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and treatment of bacterial infections.

Collaborations

One of his notable collaborators is Stephen R Baker, with whom he has worked on various projects related to antibacterial research.

Conclusion

Charles Truman Holdrege's contributions to the field of antibacterial agents highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the development of effective treatments for bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…